Epigenetic Immune Reprogramming in Murine Sepsis Survival Enhances Lipopolysaccharide-Induced Lung Injury

MLA

Rachel L. Zemans, et al. “Epigenetic Immune Reprogramming in Murine Sepsis Survival Enhances Lipopolysaccharide-Induced Lung Injury.” D94. SEPSIS BIOLOGY AND HEALTH CARE DELIVERY, May 2020. EBSCOhost, https://doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a7652.

APA

Rachel L. Zemans, Scott J. Denstaedt, Theodore J. Standiford, Michael W. Newstead, & Benjamin H. Singer. (2020). Epigenetic Immune Reprogramming in Murine Sepsis Survival Enhances Lipopolysaccharide-Induced Lung Injury. D94. SEPSIS BIOLOGY AND HEALTH CARE DELIVERY. https://doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a7652

Chicago

Rachel L. Zemans, Scott J. Denstaedt, Theodore J. Standiford, Michael W. Newstead, and Benjamin H. Singer. 2020. “Epigenetic Immune Reprogramming in Murine Sepsis Survival Enhances Lipopolysaccharide-Induced Lung Injury.” D94. SEPSIS BIOLOGY AND HEALTH CARE DELIVERY, May. doi:10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a7652.